HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shu-Chen Chu Selected Research

Transcription Factor AP-1 (Transcription Factor AP 1)

11/2019Double immunofluorescent evidence that oxidative stress-associated activation of JNK/AP-1 signaling participates in neuropeptide-mediated appetite control.
12/2013Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells.
5/2007Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shu-Chen Chu Research Topics

Disease

31Neoplasms (Cancer)
06/2022 - 01/2003
14Neoplasm Metastasis (Metastasis)
06/2022 - 07/2004
11Lung Neoplasms (Lung Cancer)
01/2018 - 07/2004
10Anorexia
11/2019 - 10/2007
7Inflammation (Inflammations)
01/2021 - 10/2004
6Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 06/2004
6Osteoarthritis
04/2008 - 01/2004
4Lewis Lung Carcinoma
01/2018 - 01/2007
3Carcinoma (Carcinomatosis)
11/2019 - 04/2006
3Mouth Neoplasms (Oral Cancer)
08/2012 - 03/2008
3Knee Osteoarthritis
01/2008 - 05/2004
3Arthritis (Polyarthritis)
10/2004 - 01/2004
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 12/2014
2Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 10/2011
2Melanoma (Melanoma, Malignant)
01/2017 - 01/2015
2Leukemia
01/2014 - 02/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2014 - 03/2008
2Squamous Cell Carcinoma of Head and Neck
08/2012 - 04/2011
2Atherosclerosis
12/2007 - 07/2002
2Iron Deficiencies
01/2007 - 01/2005
2Anemia
01/2007 - 01/2005
2Gouty Arthritis
02/2006 - 01/2004
1Colonic Neoplasms (Colon Cancer)
12/2019
1Colorectal Neoplasms (Colorectal Cancer)
12/2019
1Urogenital Neoplasms
11/2019
1Kidney Neoplasms (Kidney Cancer)
11/2019
1Hypoxia (Hypoxemia)
10/2019
1Adenocarcinoma of Lung
01/2018
1Body Weight (Weight, Body)
01/2017

Drug/Important Bio-Agent (IBA)

20Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2022 - 07/2004
18Matrix Metalloproteinases (MMPs)IBA
01/2018 - 01/2003
13Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2012 - 01/2003
10Peptide Hydrolases (Proteases)FDA Link
01/2021 - 05/2007
9Plasminogen Activators (Plasminogen Activator)IBA
09/2012 - 07/2004
8GelatinasesIBA
04/2008 - 01/2004
7Messenger RNA (mRNA)IBA
07/2011 - 09/2003
7Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2011 - 07/2002
5Biological ProductsIBA
11/2019 - 12/2007
5PhytochemicalsIBA
11/2019 - 12/2013
5GelatinIBA
04/2008 - 01/2004
4Tissue Inhibitor of Metalloproteinase-2IBA
09/2012 - 07/2002
4Silybin (Lagosa)IBA
10/2011 - 07/2004
4FibrinolysinFDA Link
04/2008 - 02/2006
3Focal Adhesion Protein-Tyrosine KinasesIBA
06/2022 - 05/2007
3Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2003
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2019 - 05/2007
3FlavonoidsIBA
11/2016 - 01/2007
32'-hydroxyflavanoneIBA
01/2014 - 01/2007
3FlavanonesIBA
01/2014 - 01/2007
3naringinIBA
09/2012 - 01/2007
3PolyphenolsIBA
09/2012 - 01/2005
3Anthocyanins (Anthocyanin)IBA
11/2006 - 01/2005
2AntioxidantsIBA
01/2021 - 02/2015
2GossypolIBA
01/2021 - 12/2019
2thymoquinoneIBA
11/2019 - 01/2014
2Cyclin BIBA
01/2017 - 01/2007
2abietic acidIBA
01/2017 - 01/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2016 - 06/2004
2epicatechin gallateIBA
08/2016 - 09/2012
2Paclitaxel (Taxol)FDA LinkGeneric
01/2015 - 10/2011
2BerberineIBA
12/2014 - 12/2007
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
07/2014 - 03/2012
2PaxillinIBA
12/2013 - 08/2012
2Gallic AcidIBA
09/2012 - 02/2009
2peonidin 3-glucosideIBA
01/2010 - 01/2005
2Antisense OligonucleotidesIBA
05/2008 - 01/2008
2Cystatin CIBA
04/2008 - 03/2004
2EnzymesIBA
04/2008 - 10/2005
2naringeninIBA
05/2007 - 01/2007
2flavanoneIBA
05/2007 - 01/2007
2Protein Kinases (Protein Kinase)IBA
05/2007 - 04/2007
2Mitogen-Activated Protein KinasesIBA
04/2007 - 10/2005
2Indicators and Reagents (Reagents)IBA
01/2007 - 01/2005
2IsoenzymesIBA
01/2007 - 01/2005
2cyanidinIBA
04/2006 - 01/2005
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2005 - 09/2003
2CytokinesIBA
10/2004 - 01/2004
1cinnamaldehyde (cinnamic aldehyde)FDA Link
06/2022
1Caspase 9IBA
06/2022
1MetalloproteinsIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2019
1Superoxides (Superoxide)IBA
11/2019
1NeuropeptidesIBA
10/2019
1Hypoxia-Inducible Factor 1IBA
10/2019
1Ghrelin ReceptorsIBA
01/2017
1Cyclin EIBA
01/2017
1acyl-ghrelinIBA
01/2017
1Type 3 Melanocortin ReceptorIBA
01/2017
1GhrelinIBA
01/2017
1AcyltransferasesIBA
01/2017
1Cytostatic AgentsIBA
11/2016
13-hydroxyflavoneIBA
11/2016
1Capsaicin (Zostrix)FDA Link
02/2015
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2014
1Cadherins (E-Cadherin)IBA
05/2014

Therapy/Procedure

4Therapeutics
04/2011 - 06/2004
3Oral Administration
06/2022 - 05/2007
2Drug Therapy (Chemotherapy)
01/2018 - 11/2016
1Subcutaneous Injections
01/2017
1Intraventricular Infusions
01/2015